Career history of Esti Hayun
Former positions of Esti Hayun
| Companies | Position | Start | End |
|---|---|---|---|
| GEFFEN RESIDENCE & RENEWAL LTD | Director of Finance/CFO | 01/01/2005 | 01/01/2010 |
| Proteologics, Inc. | Director of Finance/CFO | 01/01/2005 | 01/01/2010 |
ColBar LifeScience Ltd.
 ColBar LifeScience Ltd. Medical SpecialtiesHealth Technology ColBar LifeSciences Ltd. develops technology for tissue regeneration and tissue engineering. It manufactures and commercializes bio surgical products for applications in reconstructive medicine and tissue engineering. Its main focus is on the repair of damaged tissue in the human body like soft tissue, bone and skin. The company was founded in 1995 and is headquartered in Herzliya, Israel. | Director of Finance/CFO | - | - |
Atox Bio Ltd.
 Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Director of Finance/CFO | 01/09/2014 | - |
| Colbar R&D Ltd. | Director of Finance/CFO | - | - |
Training of Esti Hayun
| Bar-Ilan University | Graduate Degree |
| The College of Management Academic Studies | Undergraduate Degree |
Statistics
International
| Israel | 7 |
| United States | 2 |
Operational
| Director of Finance/CFO | 5 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 3 |
| Process Industries | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| GEFFEN RESIDENCE & RENEWAL LTD | Process Industries |
| Private companies | 4 |
|---|---|
| Colbar R&D Ltd. | |
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Health Technology |
ColBar LifeScience Ltd.
ColBar LifeScience Ltd. Medical SpecialtiesHealth Technology ColBar LifeSciences Ltd. develops technology for tissue regeneration and tissue engineering. It manufactures and commercializes bio surgical products for applications in reconstructive medicine and tissue engineering. Its main focus is on the repair of damaged tissue in the human body like soft tissue, bone and skin. The company was founded in 1995 and is headquartered in Herzliya, Israel. | Health Technology |
| Proteologics, Inc. |
- Stock Market
- Insiders
- Esti Hayun
- Experience
